HomeTagsCfDNA

Tag: cfDNA

Healthcare

Johns Hopkins’s AI-Powered Liquid Biopsy Shows Potential for Early Detection of Liver Fibrosis and Cirrhosis

Researchers at the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence (AI)-driven liquid biopsy approach that may enable earlier detection of liver...

Healthcare

DELFI Diagnostics Announces Equity Investment from the Merck Global Health Innovation Fund to Accelerate DELFI’s Cancer Screening AI Fragmentomics Platform

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced an equity investment by the...

Healthcare

Helio Genomics Appoints Gary Frazier as Chief Growth Officer for the Early Cancer Detection Company

Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, has announced that Gary Frazier has been selected as Chief...

Healthcare

biomodal Delivers the 6-Base Genome with a Powerful New Multiomic Solution, duet evoC

Novel solution distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample biomodal, an...

Healthcare

Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumors

TSO 500 ctDNA Version 2 delivers faster turnaround time, greater analytical sensitivity, more streamlined workflow, further enabling precision medicine. Illumina Inc., a global leader in...